Quick Order

CD80 / B7-1 Antibody, Rabbit PAb

DatasheetReviewsRelated ProductsProtocols
Human B7-1/CD80 Antibody Product Information
Immunogen:Recombinant Human CD80 / B7-1 protein (Catalog#10698-H08H)
Clone ID:
Ig Type:Rabbit IgG
Concentration:
Formulation:0.2 μm filtered solution in PBS with 5% trehalose
Preparation:Produced in rabbits immunized with purified, recombinant Human CD80 / B7-1 (rh CD80 / B7-1; Catalog#10698-H08H; Met 1-Asn 242; NP_005182.1). Total IgG was purified by Protein A affinity chromatography.
Human B7-1/CD80 Antibody Usage Guide
Specificity:Human CD80 / B7-1
Application:ELISA

ELISA: 0.5-1 μg/mL

This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Human CD80 / B7-1. The detection limit for Human CD80 / B7-1 is approximately ≤ 0.039 ng/well.

Storage:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Other B7-1/CD80 Antibody Products
Reactivity: Human  
Application: FCM  
  • Slide 1
10698-MM01-50
10698-MM01-100
10698-MM01-200
50 µg 
100 µg 
200 µg 
Add to Cart
Reactivity: Human  
Application: ELISA  
    10698-RP02-50
    10698-RP02-100
    10698-RP02-200
    50 µg 
    100 µg 
    200 µg 
    Add to Cart
    Reactivity: Human  
    Application: FCM  
    • Slide 1
    10698-MM01-F-50
    10698-MM01-F-100
    50 Tests 
    100 Tests 
    Add to Cart
    Reactivity: Human  
    Application: ELISA  IHC-P  
    • Slide 1
    • Slide 1
    10698-T24-100
    10698-T24-50
    10698-T24-200
    100 µg 
    50 µg 
    200 µg 
    Add to Cart
    Reactivity: Human  
    Application: ELISA  WB  IHC-P  
    • Slide 1
    • Slide 1
    • Slide 1
    10698-T56-100
    10698-T56-50
    10698-T56-200
    100 µg 
    50 µg 
    200 µg 
    Add to Cart
    Reactivity: Human  
    Application: ELISA  IHC-P  
    • Slide 1
    10698-R775-100
    10698-R775-50
    100 µg 
    50 µg 
    Add to Cart
    Reactivity: Human  
    Application: FCM  
    • Slide 1
    10698-MM01-P-100
    10698-MM01-P-50
    100 Tests 
    50 Tests 
    Add to Cart
    Reactivity: Mouse  
    Application: ELISA  
      50446-R018-50
      50446-R018-100
      50 µg 
      100 µg 
      Add to Cart
      Reactivity: Mouse  
      Application: ELISA  
        50446-RP01-100
        50446-RP01-200
        50446-RP01-400
        100 µg 
        200 µg 
         
        Add to Cart
        Reactivity: Mouse  
        Application: ELISA  
          50446-RP02-50
          50446-RP02-100
          50446-RP02-200
          50 µg 
          100 µg 
          200 µg 
          Add to Cart
          Reactivity: Cynomolgus  
          Application: ELISA  
            90268-RP01-100
            90268-RP01-400
            90268-RP01-200
            100 µg 
             
            200 µg 
            Add to Cart
            Reactivity: Cynomolgus  
            Application: ELISA  
              90268-T16-200
              90268-T16-100
              90268-T16-50
              200 µg 
              100 µg 
              50 µg 
              Add to Cart
              CD80/B7-1 Background

              The B-lymphocyte activation antigen B7-1 (referred to as B7), also known as CD80, is a member of cell surface immunoglobulin superfamily and is expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. As costimulatory ligands, B7-1 which exists predominantly as dimer and the related protein B7-2, interact with the costimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus constitute one of the dominant pathways that regulate T cell activation and tolerance, cytokine production, and the generation of CTL. The B7/CD28/CTLA4 pathway has the ability to both positively and negatively regulate immune responses. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

              Human CD80/B7-1 References
            • Greenfield EA, et al. (1998) CD28/B7 costimulation: a review. Crit Rev Immunol. 18(5): 389-418.
            • Zang X, et al. (2007) The B7 family and cancer therapy: costimulation and coinhibition. Clin Cancer Res. 13(18 Pt 1): 5271-9.
            • Mir MA, et al. (2008) Signaling through CD80: an approach for treating lymphomas. Expert Opin Ther Targets. 12(8): 969-79.
            • Product nameProduct name
              Size / Price
              Catalog: 10698-RP01-100
              List Price: 
              Price:      (You Save: )
              Size:
              100 µg
              200 µg
              Quantity:+-
              AvailabilityIn Stock
              Bulk Discount InquiryAdd to Cart
              All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
              Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"